Image Credit - Getty Images
Thursday, May 4, 2023
Older adults can now get the world's first RSV vaccine called Arexvy, approved by the FDA on Wednesday.
Image Credit - Getty Images
Arexvy will protect older adults against respiratory virus infection, which is common among children but can also attack the elderly.
Image Credit - Getty Images
There are more RSV vaccines in the pipeline, and CDC will decide in June whether all senior individuals need RSV protection.
Image Credit - Getty Images
The move is a great first step towards protecting older persons from serious RSV disease, says Dr. William Schaffner.
Image Credit - Getty Images
Infants get monthly doses of a protective drug during RSV season, but there is no vaccine for children.
Image Credit - Getty Images
FDA is considering approval for Sanofi and AstraZeneca's one-shot medicine for RSV protection.
Image Credit - Getty Images
The arrival of multiple potential RSV solutions is an exciting time after years of no progress, says Dr. Phil Dormitzer.
Image Credit - Getty Images
Pfizer's similar vaccine for older adults is also being considered for FDA approval.
Image Credit - Getty Images
Pfizer is also seeking approval to vaccinate pregnant women, providing protection for their babies.
Image Credit - Getty Images